Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN

Clinical trial NCT05743270 · WITHDRAWN

Trial details

NCT number: NCT05743270
Sponsor: Replimune, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck Locally Advanced Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma

Start date: 2024-01-30
Primary completion: 2026-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.